Flipping the fetal hemoglobin switch reverses sickle cell symptomsDecember 1, 2018AnemiaCellular Therapy
AML relapse after HSCT linked to potentially reversible immune changesNovember 2, 2018AMLCellular Therapy
Older age predicts mortality after alloHCT in NHL, but not relapseOctober 24, 2018Aggressive LymphomasCellular TherapyB Cell Lymphoma
Ablation plus transplant for severe scleroderma shows 11-year benefitsOctober 23, 2018Cellular Therapy
Autologous fecal transplant restores microbiota after allo-HSCTSeptember 28, 2018Patient & Survivor CareCellular Therapy
CAR T-cell studies dominate ongoing cellular therapy trialsSeptember 26, 2018Cellular TherapyAggressive LymphomasB Cell Lymphoma
NICE looks likely to reject use of Kymriah for DLBCLSeptember 24, 2018Cellular TherapyBusiness of MedicineAggressive LymphomasB Cell Lymphoma
Kymriah cost effectiveness depends on long-term outcomesSeptember 17, 2018ALLBusiness of MedicineCellular TherapyB Cell Lymphoma
Early CAR T data on P-BCMA-101 in refractory myelomaSeptember 17, 2018Multiple MyelomaCellular Therapy
England green-lights coverage of one CAR T-cell therapySeptember 6, 2018Business of MedicineALLCellular TherapyAggressive LymphomasB Cell Lymphoma
